Y90 Radioembolization Prior to Surgical Resection or Radiofrequency for Hepatocellular Carcinoma in Cirrhotic Liver

NCT01686880 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

10

Enrollment

OTHER

Sponsor class

Stopped poor recruitment and an unexpected low treatment rate

Conditions

Hepatocellular Carcinoma
Liver Cirrhosis

Interventions

DEVICE: Sirsphere trans-arterial radioembolization

Sponsor

Jules Bordet Institute